Schedule of Stock Option Activity (Details) - $ / shares |
9 Months Ended | 12 Months Ended |
|---|---|---|
Sep. 30, 2026 |
Dec. 31, 2025 |
|
| Share-Based Payment Arrangement [Abstract] | ||
| Options outstanding, beginning balance | 136,372 | |
| Weighted average exercise price, beginning balance | $ 13.43 | |
| Weighted average remaining contractual term, outstanding | 9 years 3 months 18 days | 9 years 9 months 18 days |
| Options assumed in the Vidya Acquisition | 1,047,524 | |
| Weighted average exercise price, Options assumed in the Vidya Acquisition | $ 0.01 | |
| Weighted average remaining contractual term, Options assumed in the Vidya Acquisition | 9 years 4 months 24 days | |
| Options outstanding, ending balance | 1,183,896 | 136,372 |
| Weighted average exercise price, ending balance | $ 1.56 | $ 13.43 |
| Options exercisable, ending balance | 58,745 | |
| Weighted average exercise price, exercisable | $ 19.59 | |
| Weighted average remaining contractual term, exercisable | 9 years 3 months 18 days |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options assumed in period gross. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments other than options assumed weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Expected term of award under assumed share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for vested portion of option outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|